These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16442274)
1. A microplate assay for the screening of ADAMTS-4 inhibitors. Thomas M; Sabatini M; Bensaude F; Mignard B; Ortuno JC; Caron I; Boutin JA; Ferry G Matrix Biol; 2006 May; 25(4):261-7. PubMed ID: 16442274 [TBL] [Abstract][Full Text] [Related]
2. Aggrecanase and aggrecan degradation in osteoarthritis: a review. Huang K; Wu LD J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423 [TBL] [Abstract][Full Text] [Related]
3. ADAMTS-4_v1 is a splice variant of ADAMTS-4 that is expressed as a protein in human synovium and cleaves aggrecan at the interglobular domain. Wainwright SD; Bondeson J; Caterson B; Hughes CE Arthritis Rheum; 2013 Nov; 65(11):2866-75. PubMed ID: 23897278 [TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Pratta MA; Su JL; Leesnitzer MA; Struglics A; Larsson S; Lohmander LS; Kumar S Osteoarthritis Cartilage; 2006 Jul; 14(7):702-13. PubMed ID: 16549371 [TBL] [Abstract][Full Text] [Related]
5. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover. Struglics A; Hansson M Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872 [TBL] [Abstract][Full Text] [Related]
7. Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis. Durham TB; Klimkowski VJ; Rito CJ; Marimuthu J; Toth JL; Liu C; Durbin JD; Stout SL; Adams L; Swearingen C; Lin C; Chambers MG; Thirunavukkarasu K; Wiley MR J Med Chem; 2014 Dec; 57(24):10476-85. PubMed ID: 25415648 [TBL] [Abstract][Full Text] [Related]
8. Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine. Swearingen CA; Carpenter JW; Siegel R; Brittain IJ; Dotzlaf J; Durham TB; Toth JL; Laska DA; Marimuthu J; Liu C; Brown DP; Carter QL; Wiley MR; Duffin KL; Mitchell PG; Thirunavukkarasu K Osteoarthritis Cartilage; 2010 Sep; 18(9):1150-8. PubMed ID: 20633682 [TBL] [Abstract][Full Text] [Related]
9. Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes. Takizawa M; Yatabe T; Okada A; Chijiiwa M; Mochizuki S; Ghosh P; Okada Y FEBS Lett; 2008 Aug; 582(19):2945-9. PubMed ID: 18671975 [TBL] [Abstract][Full Text] [Related]
10. Nobiletin, a citrus polymethoxy flavonoid, suppresses gene expression and production of aggrecanases-1 and -2 in collagen-induced arthritic mice. Imada K; Lin N; Liu C; Lu A; Chen W; Yano M; Sato T; Ito A Biochem Biophys Res Commun; 2008 Aug; 373(2):181-5. PubMed ID: 18541144 [TBL] [Abstract][Full Text] [Related]
11. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4. Wayne GJ; Deng SJ; Amour A; Borman S; Matico R; Carter HL; Murphy G J Biol Chem; 2007 Jul; 282(29):20991-8. PubMed ID: 17470431 [TBL] [Abstract][Full Text] [Related]
12. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. Tortorella M; Pratta M; Liu RQ; Abbaszade I; Ross H; Burn T; Arner E J Biol Chem; 2000 Aug; 275(33):25791-7. PubMed ID: 10827174 [TBL] [Abstract][Full Text] [Related]
13. Evidence of a novel aggrecan-degrading activity in cartilage: Studies of mice deficient in both ADAMTS-4 and ADAMTS-5. Rogerson FM; Stanton H; East CJ; Golub SB; Tutolo L; Farmer PJ; Fosang AJ Arthritis Rheum; 2008 Jun; 58(6):1664-73. PubMed ID: 18512787 [TBL] [Abstract][Full Text] [Related]
14. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system. Powell AJ; Little CB; Hughes CE Arthritis Rheum; 2007 Sep; 56(9):3010-9. PubMed ID: 17763444 [TBL] [Abstract][Full Text] [Related]
15. The cleavage of biglycan by aggrecanases. Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997 [TBL] [Abstract][Full Text] [Related]
16. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). Tortorella MD; Pratta M; Liu RQ; Austin J; Ross OH; Abbaszade I; Burn T; Arner E J Biol Chem; 2000 Jun; 275(24):18566-73. PubMed ID: 10751421 [TBL] [Abstract][Full Text] [Related]
17. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Tortorella MD; Burn TC; Pratta MA; Abbaszade I; Hollis JM; Liu R; Rosenfeld SA; Copeland RA; Decicco CP; Wynn R; Rockwell A; Yang F; Duke JL; Solomon K; George H; Bruckner R; Nagase H; Itoh Y; Ellis DM; Ross H; Wiswall BH; Murphy K; Hillman MC; Hollis GF; Newton RC; Magolda RL; Trzaskos JM; Arner EC Science; 1999 Jun; 284(5420):1664-6. PubMed ID: 10356395 [TBL] [Abstract][Full Text] [Related]
18. Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition. Hu Y; Xing L; Thomason JR; Xiang J; Ipek M; Guler S; Li H; Sabatini J; Chockalingam P; Reifenberg E; Sheldon R; Morris EA; Georgiadis KE; Tam S Bioorg Med Chem Lett; 2011 Nov; 21(22):6800-3. PubMed ID: 21982494 [TBL] [Abstract][Full Text] [Related]
19. ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan. East CJ; Stanton H; Golub SB; Rogerson FM; Fosang AJ J Biol Chem; 2007 Mar; 282(12):8632-40. PubMed ID: 17255106 [TBL] [Abstract][Full Text] [Related]
20. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. Verma P; Dalal K J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]